314
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Antenatal administration of vitamin K1: relationship to vitamin K-dependent coagulation factors and incidence rate of periventricular-intraventricular hemorrhage in preterm infants; Egyptian randomized controlled trial

, , , , &
Pages 816-820 | Received 05 Jun 2013, Accepted 21 Aug 2013, Published online: 27 Sep 2013

References

  • Pichler E, Pichler L. The neonatal coagulation system and the vitamin K deficiency bleeding: a mini review. Wien Med Wochenschr 2008;158:385–95
  • Kazzi NJ, Ilang NB, Liang KC, et al. Maternal administration of vitamin K does not improve the coagulation profile of preterm infants. Pediatrics 1989;84:1045–50
  • American Academy of Pediatrics. Committee on Nutrition. Nutritional needs of preterm infants. In: Kleinman RE, ed. Pediatric nutrition handbook. 5th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2004:350–1
  • Shearer MJ. Vitamin K deficiency bleeding (VKDB) in early infancy. Blood Rev 2009;23:49–59
  • Palis J, Segel GB. Hematology of the fetus and newborn. In: Kaushansky K, Lichtman MA, Beutler E, et al., eds. Williams hematology. New York: McGraw-Hill; 2009:87–104
  • Ozdemir MA, Karakukcu M, Per H, et al. Late-type vitamin K deficiency bleeding: experience from 120 patients. Childs Nerv Syst 2012;28:247–51
  • Van de Bor M, de Ouden L. School performance in adolescents with and without periventricular–intraventricular hemorrhage in the neonatal period. Semin Perinatal 2004;28:295–303
  • Donn SM, Stuck KJ. Neonatal germinal matrix hemorrhage: evidence of a progressive lesion. J Pediatr 1981;99:459–61
  • Al-Shawaf EM, Al-Alaiyan SA, Aqeel AY, Gamal MH. The use of indomethacin for the prevention of intracranical brain hemorrhage in high-risk neonates. Saudi Med J 2000;21:274–7
  • Schulte J, Osborne J, Benson JW, et al. Developmental outcome of the use of etamsylate for prevention of periventricular hemorrhage in a randomized controlled trial. Arch Dis Child Fetal Neonatal Ed 2005;90:F31–5
  • Liu J, Wang Q, Gao F, et al. Maternal antenatal administration of vitamin K1 results in increasing the activities of vitamin K-dependent coagulation factors in umbilical blood and in decreasing the incidence rate of periventricular–intraventricular hemorrhage in premature infants. J Perinat Med 2006;34:173–6
  • Ballard JL, Khoury JC, Wedig K, et al. New Ballard score, expanded to include extremely premature infants. J Pediatr 1991;119:417–23
  • Apgar V. A proposal for a new method of evaluation of the newborn infant. Cure Res Anesth Analg 1953;32:260–7
  • Thorp JA, Caspers DR, Cohen GR, et al. the effect of combined antenatal vitamin k and Phenobarbital therapy on umbilical blood coagulation studies in infant less than 34 weeks gestation. Obstet Gynecol 1995;86:982–9
  • Forestier F, Daffos F, Rainaut M, et al. Vitamin K-dependent proteins in fetal hemostasis at mid trimester of pregnancy. Thromb Haemost 1985;53:401–3
  • Crowther CA, Crosby DD, Henderson-Smart DJ. Vitamin K prior to preterm birth for preventing neonatal periventricular hemorrhage. Cochrane Database Syst Rev 2010;20:CD000229
  • Dickson RC, Stubbs TM, Lazarchick J. Antenatal vitamin K therapy of the low-birth-weight infant. Am J Obstet Gyncol 1994;170:85–9
  • Yang YM, Simon N, Maertens B, et al. Maternal- fetal transport of vitamin K1 and its effects on coagulation in premature infants. J Pediatr 1989;115:1009–12
  • McNinch AW, Upton C, Samuel M, et al. Plasma concentration after oral or intramuscular vitamin k1 in neonates. Arch Dis Child 1985;60:814–18
  • Pomerance JJ, Teal JG, Gogolok JF. Maternally administered antenatal vitamin K1: effect on neonatal prothrombin activity, partial thromboplastin time, and intraventricular hemorrhage. Obstet Gynecol 1987;70:235–41
  • Morales WJ, Angel JL, O'Brien UF. The use of antenatal vitamin K in the prevention of early neonatal intraventricular hemorrhage. Am J Obstet Gynecol 1988;159:774–9
  • Liu J, JW He, Q Wang. The incidence of periventricular intraventricular hemorrhage in preterm infants and its high risk factors. Zhonghua Er Ke Za Zhi 2005;43:216–17

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.